Literature DB >> 23449108

RNA-based vaccination: sending a strong message.

David B Weiner1.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23449108      PMCID： PMC3589163          DOI： 10.1038/mt.2013.26

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  13 in total

Review 1.  Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination.

Authors:  Christophe J Desmet; Ken J Ishii
Journal:  Nat Rev Immunol       Date:  2012-06-22       Impact factor: 53.106

2.  Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.

Authors:  Katalin Karikó; Hiromi Muramatsu; Frank A Welsh; János Ludwig; Hiroki Kato; Shizuo Akira; Drew Weissman
Journal:  Mol Ther       Date:  2008-09-16       Impact factor: 11.454

3.  Nonviral delivery of self-amplifying RNA vaccines.

Authors:  Andrew J Geall; Ayush Verma; Gillis R Otten; Christine A Shaw; Armin Hekele; Kaustuv Banerjee; Yen Cu; Clayton W Beard; Luis A Brito; Thomas Krucker; Derek T O'Hagan; Manmohan Singh; Peter W Mason; Nicholas M Valiante; Philip R Dormitzer; Susan W Barnett; Rino Rappuoli; Jeffrey B Ulmer; Christian W Mandl
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

Review 4.  Non-viral amplification systems for gene transfer: vectors based on alphaviruses.

Authors:  C Smerdou; P Liljeström
Journal:  Curr Opin Mol Ther       Date:  1999-04

Review 5.  DNA vaccines: progress and challenges.

Authors:  John J Donnelly; Britta Wahren; Margaret A Liu
Journal:  J Immunol       Date:  2005-07-15       Impact factor: 5.422

6.  Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines.

Authors:  Charlotte Pollard; Joanna Rejman; Winni De Haes; Bernard Verrier; Ellen Van Gulck; Thomas Naessens; Stefaan De Smedt; Pieter Bogaert; Johan Grooten; Guido Vanham; Stefaan De Koker
Journal:  Mol Ther       Date:  2012-09-25       Impact factor: 11.454

Review 7.  Electroporation delivery of DNA vaccines: prospects for success.

Authors:  Niranjan Y Sardesai; David B Weiner
Journal:  Curr Opin Immunol       Date:  2011-04-27       Impact factor: 7.486

Review 8.  DNA vaccines: ready for prime time?

Authors:  Michele A Kutzler; David B Weiner
Journal:  Nat Rev Genet       Date:  2008-10       Impact factor: 53.242

Review 9.  Cancer immunotherapy with mRNA-transfected dendritic cells.

Authors:  Eli Gilboa; Johannes Vieweg
Journal:  Immunol Rev       Date:  2004-06       Impact factor: 12.988

Review 10.  Polynucleotide-mediated immunization therapy of cancer.

Authors:  R M Conry; A F LoBuglio; D T Curiel
Journal:  Semin Oncol       Date:  1996-02       Impact factor: 4.929
View more
  7 in total

1.  In planta production of flock house virus transencapsidated RNA and its potential use as a vaccine.

Authors:  Yiyang Zhou; Payal D Maharaj; Jyothi K Mallajosyula; Alison A McCormick; Christopher M Kearney
Journal:  Mol Biotechnol       Date:  2015-04       Impact factor: 2.695

2.  Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose.

Authors:  Jasdave S Chahal; Omar F Khan; Christopher L Cooper; Justine S McPartlan; Jonathan K Tsosie; Lucas D Tilley; Saima M Sidik; Sebastian Lourido; Robert Langer; Sina Bavari; Hidde L Ploegh; Daniel G Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-05       Impact factor: 11.205

3.  NPM-ALK-reactive T-cell responses in children and adolescents with NPM-ALK positive anaplastic large cell lymphoma.

Authors:  Vijay Kumar Singh; Sebastian Werner; Simone Schwalm; Volker Lennerz; Stephanie Ruf; Serena Stadler; Holger Hackstein; Alfred Reiter; Thomas Wölfel; Christine Damm-Welk; Wilhelm Woessmann
Journal:  Oncoimmunology       Date:  2019-06-26       Impact factor: 8.110

Review 4.  COVID-19 Vaccine Frontrunners and Their Nanotechnology Design.

Authors:  Young Hun Chung; Veronique Beiss; Steven N Fiering; Nicole F Steinmetz
Journal:  ACS Nano       Date:  2020-10-09       Impact factor: 15.881

Review 5.  mRNA capping: biological functions and applications.

Authors:  Anand Ramanathan; G Brett Robb; Siu-Hong Chan
Journal:  Nucleic Acids Res       Date:  2016-06-17       Impact factor: 16.971

6.  Nanoliposomes for Safe and Efficient Therapeutic mRNA Delivery: A Step Toward Nanotheranostics in Inflammatory and Cardiovascular Diseases as well as Cancer.

Authors:  Meike-Kristin Abraham; Karlheinz Peter; Tatjana Michel; Hans Peter Wendel; Stefanie Krajewski; Xiaowei Wang
Journal:  Nanotheranostics       Date:  2017-04-05

Review 7.  Strategies for inducing effective neutralizing antibody responses against HIV-1.

Authors:  Iván Del Moral-Sánchez; Kwinten Sliepen
Journal:  Expert Rev Vaccines       Date:  2019-12-02       Impact factor: 5.217
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.